Variant report
Variant | nsv968597 |
---|---|
Chromosome Location | chr9:15522707-15527787 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:50)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:50 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr9:15527023-15527263 | GM12878 | blood: | n/a | n/a |
2 | CEBPB | chr9:15527034-15527402 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr9:15527008-15527346 | K562 | blood: | n/a | n/a |
4 | CTCF | chr9:15526640-15526790 | AoAF | blood vessel: | n/a | n/a |
5 | CTCF | chr9:15524273-15524316 | Spleen_OC | spleen: | n/a | n/a |
6 | EGR1 | chr9:15527543-15527739 | GM12878 | blood: | n/a | n/a |
7 | GATA2 | chr9:15526974-15527329 | K562 | blood: | n/a | n/a |
8 | HEY1 | chr9:15527474-15527897 | K562 | blood: | n/a | chr9:15527720-15527735 chr9:15527709-15527724 chr9:15527697-15527712 |
9 | HEY1 | chr9:15527512-15527915 | HepG2 | liver: | n/a | chr9:15527720-15527735 chr9:15527709-15527724 chr9:15527697-15527712 |
10 | HEY1 | chr9:15527439-15527765 | K562 | blood: | n/a | chr9:15527720-15527735 chr9:15527709-15527724 chr9:15527697-15527712 |
11 | IRF1 | chr9:15523299-15523302 | K562 | blood: | n/a | n/a |
12 | MAFF | chr9:15524898-15525184 | HepG2 | liver: | n/a | chr9:15525036-15525054 |
13 | MAFF | chr9:15524907-15525130 | K562 | blood: | n/a | chr9:15525036-15525054 |
14 | MAFK | chr9:15524886-15525173 | HepG2 | liver: | n/a | chr9:15525038-15525053 |
15 | MAFK | chr9:15524867-15525206 | HepG2 | liver: | n/a | chr9:15525038-15525053 |
16 | PAX5 | chr9:15527309-15527754 | GM12878 | blood: | n/a | n/a |
17 | POLR2A | chr9:15527326-15528011 | GM12878 | blood: | n/a | n/a |
18 | POLR2A | chr9:15527723-15527854 | A549 | lung: | n/a | n/a |
19 | POLR2A | chr9:15527396-15527757 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | POLR2A | chr9:15527485-15527865 | GM12878 | blood: | n/a | n/a |
21 | POLR2A | chr9:15526902-15527199 | Hela-S3 | cervix: | n/a | n/a |
22 | POLR2A | chr9:15526977-15527146 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | POLR2A | chr9:15527519-15527715 | A549 | lung: | n/a | n/a |
24 | POLR2A | chr9:15527539-15527763 | H1-hESC | embryonic stem cell: | n/a | n/a |
25 | POLR2A | chr9:15527545-15527675 | A549 | lung: | n/a | n/a |
26 | POLR2A | chr9:15527405-15527790 | GM12878 | blood: | n/a | n/a |
27 | POLR2A | chr9:15527439-15527827 | A549 | lung: | n/a | n/a |
28 | POLR2A | chr9:15527360-15527919 | Hela-S3 | cervix: | n/a | n/a |
29 | POLR2A | chr9:15527384-15527896 | Hela-S3 | cervix: | n/a | n/a |
30 | POLR2A | chr9:15527474-15527710 | H1-hESC | embryonic stem cell: | n/a | n/a |
31 | POLR2A | chr9:15527557-15527713 | A549 | lung: | n/a | n/a |
32 | POLR2A | chr9:15526974-15527316 | GM12878 | blood: | n/a | n/a |
33 | POLR2A | chr9:15527738-15527826 | A549 | lung: | n/a | n/a |
34 | POLR2A | chr9:15527765-15527881 | H1-hESC | embryonic stem cell: | n/a | n/a |
35 | POLR2A | chr9:15527537-15527683 | HepG2 | liver: | n/a | n/a |
36 | POLR2A | chr9:15527211-15527975 | H1-hESC | embryonic stem cell: | n/a | n/a |
37 | POLR2A | chr9:15527576-15527683 | K562 | blood: | n/a | n/a |
38 | POLR2A | chr9:15527330-15528041 | GM12892 | blood: | n/a | n/a |
39 | POLR2A | chr9:15527550-15527691 | GM12878 | blood: | n/a | n/a |
40 | POU2F2 | chr9:15527376-15527803 | GM12878 | blood: | n/a | chr9:15527731-15527743 chr9:15527728-15527740 |
41 | POU2F2 | chr9:15526997-15527345 | GM12878 | blood: | n/a | n/a |
42 | SIN3AK20 | chr9:15527537-15527678 | HepG2 | liver: | n/a | n/a |
43 | TAL1 | chr9:15526983-15527344 | K562 | blood: | n/a | n/a |
44 | USF1 | chr9:15527038-15527366 | K562 | blood: | n/a | chr9:15527220-15527231 |
45 | USF1 | chr9:15527069-15527336 | HepG2 | liver: | n/a | chr9:15527220-15527231 |
46 | USF2 | chr9:15527063-15527376 | HepG2 | liver: | n/a | chr9:15527220-15527231 |
47 | USF2 | chr9:15527114-15527318 | Hela-S3 | cervix: | n/a | chr9:15527220-15527231 |
48 | WRNIP1 | chr9:15525819-15526000 | GM12878 | blood: | n/a | n/a |
49 | ZBTB33 | chr9:15526882-15527259 | K562 | blood: | n/a | n/a |
50 | ZBTB33 | chr9:15527306-15527859 | K562 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:15512114..15513693-chr9:15523609..15526046,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PSIP1-2 | chr9:15525782-15526079 | NONHSAT130270 |
No data |
No data |
Variant related genes | Relation type |
---|---|
FTH1P12 | TF binding region |
RN7SL98P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560923733 | chr9:15522711-15522712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531469034 | chr9:15522712-15522713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143531389 | chr9:15522741-15522742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183090108 | chr9:15522753-15522754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188370426 | chr9:15522767-15522768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191718814 | chr9:15522778-15522779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566003283 | chr9:15522779-15522780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536750011 | chr9:15522787-15522788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs58915725 | chr9:15522800-15522801 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs532519072 | chr9:15522836-15522837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534653683 | chr9:15522842-15522843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374855329 | chr9:15522854-15522855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs148065741 | chr9:15522858-15522859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116223666 | chr9:15522872-15522873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376749355 | chr9:15522886-15522887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577658328 | chr9:15522916-15522917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs141803342 | chr9:15522965-15522966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs59355275 | chr9:15522981-15522982 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs10962055 | chr9:15523032-15523033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542723796 | chr9:15523036-15523037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370735743 | chr9:15523053-15523054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs115303759 | chr9:15523058-15523059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375094447 | chr9:15523059-15523060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549415676 | chr9:15523061-15523062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571202195 | chr9:15523096-15523097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112960000 | chr9:15523107-15523108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs59246471 | chr9:15523109-15523110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144102833 | chr9:15523110-15523111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114284183 | chr9:15523121-15523122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547225851 | chr9:15523127-15523128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188264891 | chr9:15523144-15523145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536312822 | chr9:15523182-15523183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555029412 | chr9:15523209-15523210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537339267 | chr9:15523228-15523229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570190539 | chr9:15523256-15523257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs150163446 | chr9:15523260-15523261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192520203 | chr9:15523291-15523292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77152921 | chr9:15523303-15523304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs57142629 | chr9:15523304-15523305 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs553256789 | chr9:15523310-15523311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574962224 | chr9:15523392-15523393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542087566 | chr9:15523436-15523437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184784440 | chr9:15523451-15523452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190085992 | chr9:15523472-15523473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542976660 | chr9:15523474-15523475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182099840 | chr9:15523494-15523495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553172139 | chr9:15523497-15523498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559123432 | chr9:15523572-15523573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs76097061 | chr9:15523585-15523586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs547683884 | chr9:15523594-15523595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:15521400-15523000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr9:15522600-15522800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr9:15523000-15528200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr9:15524400-15525800 | Enhancers | HUVEC | blood vessel |
5 | chr9:15525000-15525400 | Enhancers | Brain Angular Gyrus | brain |